Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What information is available on company profile pages?

Company profile pages provide comprehensive information including financial statements, earnings data, analyst ratings, institutional ownership, insider trading, SEC filings, and detailed business analysis.

How do I analyze a company's financial health?

Use our financial metrics including P/E ratio, debt-to-equity, revenue growth, profit margins, and cash flow analysis to evaluate a company's financial strength and growth potential.

How do I analyze TEVA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TEVA investment potential.

What is TEVA stock price today?

The current TEVA stock price is $34.31 as of 13 Feb '26. Get real-time TEVA stock price, historical data, and price charts on Financhill.

Is TEVA a good investment?

Evaluate TEVA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

What does Teva Pharmaceutical Industries Ltd. (TEVA) do?

Teva Pharmaceutical Industries Ltd. (TEVA) is a publicly traded company. View detailed company information, business model, financial statements, and corporate data on our TEVA company profile page.

How to buy TEVA stock?

To buy TEVA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TEVA?

View detailed market capitalization data and company valuation metrics for TEVA on our comprehensive analysis page.

What is the P/E ratio of TEVA?

Use our fundamental analysis tools to view TEVA P/E ratio and compare valuation metrics with industry peers.

What are TEVA earnings?

View TEVA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Buy

65

TEVA Quote, Financials, Valuation and Earnings

Last price:

$33.92

Seasonality move :

4.66%

Day range:

$33.92 - $34.80

52-week range:

$12.47 - $37.35

Dividend yield:

0%

P/E ratio:

28.16x

P/S ratio:

2.29x

P/B ratio:

5.05x

Volume:

5.5M

Avg. volume:

10.7M

1-year change:

106.81%

Market cap:

$40B

Revenue:

$17.5B

EPS (TTM):

$1.22

Teva Pharmaceutical Industries Ltd. SEC Filings

Company	Filed	Form Type	Description
TEVA Teva Pharmaceutical Industries Ltd.	05/08/2024	10-Q	10-Q filing on 05/08/2024	View Form
TEVA Teva Pharmaceutical Industries Ltd.	02/12/2024	10-K	10-K filing on 02/12/2024	View Form
TEVA Teva Pharmaceutical Industries Ltd.	11/09/2023	10-Q	10-Q filing on 11/09/2023	View Form
TEVA Teva Pharmaceutical Industries Ltd.	08/02/2023	10-Q	10-Q filing on 08/02/2023	View Form
TEVA Teva Pharmaceutical Industries Ltd.	05/10/2023	10-Q	10-Q filing on 05/10/2023	View Form
TEVA Teva Pharmaceutical Industries Ltd.	02/10/2023	10-K	10-K filing on 02/10/2023	View Form
TEVA Teva Pharmaceutical Industries Ltd.	11/03/2022	10-Q	10-Q filing on 11/03/2022	View Form
TEVA Teva Pharmaceutical Industries Ltd.	07/27/2022	10-Q	10-Q filing on 07/27/2022	View Form
TEVA Teva Pharmaceutical Industries Ltd.	05/03/2022	10-Q	10-Q filing on 05/03/2022	View Form
TEVA Teva Pharmaceutical Industries Ltd.	02/09/2022	10-K	10-K filing on 02/09/2022	View Form
TEVA Teva Pharmaceutical Industries Ltd.	10/27/2021	10-Q	10-Q filing on 10/27/2021	View Form
TEVA Teva Pharmaceutical Industries Ltd.	07/28/2021	10-Q	10-Q filing on 07/28/2021	View Form
TEVA Teva Pharmaceutical Industries Ltd.	04/28/2021	10-Q	10-Q filing on 04/28/2021	View Form
TEVA Teva Pharmaceutical Industries Ltd.	02/10/2021	10-K	10-K filing on 02/10/2021	View Form
TEVA Teva Pharmaceutical Industries Ltd.	11/05/2020	10-Q	10-Q filing on 11/05/2020	View Form
TEVA Teva Pharmaceutical Industries Ltd.	08/05/2020	10-Q	10-Q filing on 08/05/2020	View Form
TEVA Teva Pharmaceutical Industries Ltd.	05/07/2020	10-Q	10-Q filing on 05/07/2020	View Form
TEVA Teva Pharmaceutical Industries Ltd.	02/21/2020	10-K	10-K filing on 02/21/2020	View Form
TEVA Teva Pharmaceutical Industries Ltd.	11/07/2019	10-Q	10-Q filing on 11/07/2019	View Form
TEVA Teva Pharmaceutical Industries Ltd.	08/07/2019	10-Q	10-Q filing on 08/07/2019	View Form
TEVA Teva Pharmaceutical Industries Ltd.	05/02/2019	10-Q	10-Q filing on 05/02/2019	View Form
TEVA Teva Pharmaceutical Industries Ltd.	02/19/2019	10-K	10-K filing on 02/19/2019	View Form
TEVA Teva Pharmaceutical Industries Ltd.	11/01/2018	10-Q	10-Q filing on 11/01/2018	View Form
TEVA Teva Pharmaceutical Industries Ltd.	08/02/2018	10-Q	10-Q filing on 08/02/2018	View Form
TEVA Teva Pharmaceutical Industries Ltd.	05/03/2018	10-Q	10-Q filing on 05/03/2018	View Form
TEVA Teva Pharmaceutical Industries Ltd.	02/12/2018	10-K	10-K filing on 02/12/2018	View Form

Related Companies

Get TEVA Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

TEVA

Sector

P/E ratio

28.16x

23.34x

PEG ratio

-0.09x

-0.01x

P/B ratio

5.05x

1.72x

Price / LTM sales

2.29x

1.51x

Growth Metrics

TEVA

Sector

Revenue growth

12.42%

3.21%

Earnings growth

313.26%

10.12%

Revenue (5-year growth)

0.94%

6.27%

Earnings forecast

$0.64

-$0.19

Profitability

TEVA

Sector

Profitability FY 2025

$9.1B

$2.7M

Return on invested capital

5.9%

-33.62%

Return on assets

3.6%

-29.68%

Return on equity

20.99%

-38.89%

Earnings Date

Last Earnings Date

Jan

28

Next Earnings Date

May

6

Estimated Next Earnings Date

Apr

29

Balance Sheet

TEVA

Sector

Total cash

$3.6B

$25M

Short term investments

--

$23.9M

Total assets

$40.7B

$72.8M

Long term debt

$17.1B

$2.5M

Stock Ideas

Buy

56

Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy or Sell?

Buy

58

Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy or Sell?

Sell

40

Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Buy or Sell?

Alerts

Buy

91

TDC alert for Feb 12

Teradata Corp. [TDC] is down 11.64% over the past day.

Buy or Sell?

Buy

67

DIOD alert for Feb 12

Diodes, Inc. [DIOD] is down 7.63% over the past day.

Buy or Sell?

Buy

77

VRT alert for Feb 12

Vertiv Holdings Co. [VRT] is down 4.79% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Teva Pharmaceutical Industries Ltd. SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get TEVA Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?

Is Lumentum The Best Laser Stock to Buy?

Is Planet Fitness Stock Undervalued?

Stock Ideas

Is NVDA Stock a Buy?

Is AAPL Stock a Buy?

Is GOOG Stock a Buy?

Alerts

TDC alert for Feb 12

DIOD alert for Feb 12

VRT alert for Feb 12

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

Stocks by Sector

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS